MPR Weekly Dose

This week on the Pod: The FDA issues guidance for COVID-19 vaccine development; Accuracy in COVID-19 antibody testing; How statins may improve outcomes for hospitalized COVID-19 patients; and in non-COVID-related news there's a new drug approvals in breast cancer and Dravet syndome.

This week on the Pod: Over-the-counter med recalls; a nasal spray approved for diabetic gastroparesis; reports of an uptick in p enicillin-, ciprofloxacin-resistant meningococci; and in pandemic-related news, a possible inhaled version of remdesivir, and colchicine as a potential treatment. 

This week we cover the latest in the rapidly shifting perception of chloroquine and hydroxychloroquine; The polio vaccine as a potential protector against COVID-19; A new approval for Gardasil 9; And the American Gastroenterological Association draw up new guidelines for probiotic use as a treatment in gastrointestinal disorders.

This week on the pod we cover the latest COVID19 news, including  antibody tests and their accuracy; A study aiming to examine treatments in children; The potential benefit of Acalabrutinib in severe cases; The WHO's Technical Lead on COVID-19 having to backpedal a statement on transmission; And many states lodge record high numbers of infections.

This week on the pod we look at results from a COVID-19 prevention trial of hydroxychloroquine; A vaccine arrival date prediction by Dr Fauci; A FDA notification regarding vial caps; A look into prescription patterns during COVID-19; And an antibody treatment trial begins. 

Today's pod covers important news regarding hydroxychloroquine; The efficacy of dietary supplements as a means to manage or prevent COVID-19; The first non-hormonal contraceptive gel approved by the FDA; And an expanded approval for dupilumab.

This week we cover the latest COVID-19 developments including: reports of false negatives with Abbott's diagnostic test; the immune globulin therapy linked to recovery in multisystem inflammatory syndrome in children, related to COVID-19; and the clinical trials set to be initiated for an umbilical cord stem cell therapy and a high dose IV immune globulin therapy.

This week we cover the latest COVID-19 developments including a triple antiviral therapy that looks promising, Emergency Use Authorizations granted to diagnostics and critical meds, Moderna's investigational vaccine gets Fast Tracked, and the National Institute of Health's remdesivir plus baricitinib trial.

This week we cover the the risk of antihypertensive med use during the pandemic; The Emergency Use Authorization for remdesivir in hospitalized patients with suspected or confirmed COVID-19; The addition of a Boxed Warning to Montelukast; A new Farxiga indication; And a novel treatment for acute migraines.

There has been a lot of recent developments in possible COVID-19 treatments. I'll go over the latest status with remdesivir, hydroxychloroquine, sarilumab, and remestemcel-L, and also the treatment guidelines for COVID-19 issued by the National Institute of Health. 

On today's podcast we run through the top COVID-19 stories including a steep rise in poison control calls; the authorization of an at-home testing kit; The hydroxychloroquine trial that's beginning soon; The trial evaluating ruxolitinib for COVID-19 associated cytokine storms; and the lab failures which have led to ineffective COVID-19 tests being sent from the CDC to nearly all of the 100 state a...

We run through the latest COVID-19 news including results from a remdesivir trial; The blood purification system OK'd for patients in the ICU; A chloroquine trial halted early due to deaths; The saliva test that detects COVID19; And a bleaching agent product that is claiming to prevent COVID-19.

This week we run through the latest COVID-19 news including the shortage of critical meds, The CDC U-turn on face mask recommendations, Remdesivir trial enrollment, testing for COVID-19 antibodies, and new guidance from the FDA on blood donations aimed at helping maintain the supply. 

This episodes covers the latest COVID-19 news including drug shortages, a new point-of-care diagnostic tool, the role of vitamin C, misuse of non-pharmacological chloroquine, and also some big news about a popular heartburn drug.

This week we talk about the latest on COVID-19, including the virus in relation to NSAID use; the pandemics knock on effect on drug shortages; a safety alert for fecal microbiota transplants; and potential flaws in EpiPen devices.

This week we talk about a phase 1 vaccine trial for COVID-19 underway in Seattle; Concerns over COVID-19 and ACE inhibitor, ARB use; Safety labeling changes for SGLT2 inhibitors; A biosimilar to Herceptin; And new graphic warnings for cigarette packages.

Today we talk about the latest COVID-19 news; New approvals for chronic fibrosing interstitial lung diseases and Cushing disease; and stronger safety warnings for montelukast.

Today we talk about the ban on certain electrical stimulation devices, the latest COVID-19 news, a first generic of Daraprim, a New Drug Application for a potential microneedle migraine treatment patch, and a first over-the-counter combination of ibuprofen and acetaminophen: Advil Dual Action.

This week on the pod we cover a first-in-class cholesterol lowering therapy; a new indication for Trulicity; Macrolide prescriptions in the first trimester and their relation to fetal malformations; a new fragile X diagnostic test; and a migraine prevention IV treatment.

This week on the pod we cover the withdrawal of Belviq, the weight-loss drug, from the market; the over-the-counter approval of diclofenac gel and olopatadine eye drops; a new contraceptive transdermal patch; a possible vaccine for ricintoxin; and new research finds that hundreds of sellers are using Craigslist to sell prescribing medications.

This week on the pod we cover an insulin pump recall; Pharmacies running out of supplies in light of Covid-19 fears; Investigational Alzheimer disease treatments not meeting trial end points; A new cardiac ultrasound device; and a new oral testosterone replacement therapy.

This week on the Pod we cover the approval of the first oral therapy for peanut allergy; The 2020 immunization schedule; The latest on the coronavirus, including the CDC's shipment of test kits; The withdrawal of an antibiotic; and results from the FDA investigation into possible impurities in metformin.

This week we discuss the latest news surrounding the novel coronavirus, including the WHO's decision to declare the virus a global emergency; A new triple combo therapy in type 2 diabetes; Updated Tdap vaccination recommendations; An FDA warning regarding serious clozapine side effects; And news of possible cybersecurity vulnerabilities with certain patient monitoring devices.

This week we cover the CDC coronavirus health advisory; A possible oral influenza vaccine; A new treatment to reduce the risk of MACE; An FDA Committee vote; And the first approved treatment for thyroid eye disease.

This week we cover the approval of a cocaine nasal solution; 23andMe's entry into the drug development; The recall of an epilepsy and bipolar treatment; A new nasal spray for seizure patients; And the weight loss drug that may be linked to cancer.